Nuvectis Pharma, Inc.
NASDAQ:NVCT
6.7 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||||
| Nettowinst
| -4.428 | -4.171 | -6.622 | -5.881 | -5.708 | -4.049 | -6.696 | -5.877 | -3.569 | -2.943 | -2.261 | -4.668 | -5.938 | -0.023 |
| Afschrijvingen & Amortisatie
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 1.262 | 1.296 | 1.22 | 1.133 | 0.95 | 1.402 | 0.482 | 0.559 | 0.51 | 0.156 | 0.185 | 0.136 | 1.571 | 0 |
| Verandering in Werkkapitaal
| 0.146 | -1.483 | 1.552 | 1.504 | 0.675 | -2.13 | 2.698 | 0.894 | 0.516 | -0.289 | 1.009 | 0.106 | 0.356 | 0.023 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 0.087 | -1.012 | 0.021 | 0 | -0.293 | -0.814 | 0 | 0 | 0 | 0.542 | 1.479 | 0.106 | 0 | 0 |
| Overig Werkkapitaal
| 0.059 | -0.471 | 1.531 | 1.504 | 0.675 | -2.13 | 2.698 | 0.894 | 0.516 | -0.831 | -0.47 | 0.106 | 0.356 | 0 |
| Overige Niet-Contante Posten
| 1.175 | 2.308 | 1.199 | 1.133 | 0.95 | 1.402 | 0.482 | 0.559 | 0.51 | 0.156 | 0.185 | 0.136 | 1.571 | 0.023 |
| Kasstroom uit Operationele Activiteiten
| -3.02 | -4.358 | -3.85 | -3.244 | -4.083 | -4.777 | -3.516 | -4.424 | -2.543 | -3.076 | -1.067 | -4.426 | -4.011 | 0 |
| Investeringsactiviteiten: | ||||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financieringsactiviteiten: | ||||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 1.672 | 4.696 | 0.917 | 1.126 | 3.262 | 0.252 | -0.131 | 15.879 | -0.578 | 16 | 0 | 4.021 | 11.225 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -0.055 | -0.153 | 0.016 | -0.423 | 9.953 | -0.45 | -0.131 | -1.387 | -0.578 | -1.973 | 0 | 4.021 | 11.225 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 1.672 | 4.696 | 0.917 | 0.703 | 13.215 | 0.252 | -0.131 | 14.492 | -0.578 | 14.027 | 0 | 4.021 | 11.225 | 0 |
| Overige Informatie: | ||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -1.348 | 0.338 | -2.933 | -2.541 | 9.132 | -4.525 | -3.647 | 10.068 | -3.121 | 10.951 | -1.067 | -0.405 | 7.214 | 0 |
| Kaspositie aan het Einde van de Periode
| 18.116 | 19.464 | 19.126 | 22.059 | 24.6 | 15.468 | 19.993 | 23.64 | 13.572 | 16.693 | 5.742 | 6.809 | 7.214 | 0 |